NEW YORK, May 30 – RheoGene, a privately held gene expression company based in Charlottesville, Va., announced Wednesday that it had appointed several genomics industry heavyweights to its scientific advisory board.

Michael Ashburner, the joint head of the European Molecular Biology Laboratory and the European Bioinformatics Institute, and Leroy Hood, director of the Institute for Systems Biology, were both named to the board as was Jeffrey Trent, scientific director of the National Human Genome Research Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.